10x Genomics (TXG)
(Delayed Data from NSDQ)
$13.36 USD
-0.34 (-2.48%)
Updated Nov 4, 2025 04:00 PM ET
After-Market: $13.36 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, 10x Genomics has a market cap of $16.63B, which represents its share price of $148.85 multiplied by its outstanding shares number of 111.71M. As a large-cap company, TXG's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
TXG 13.36 -0.34(-2.48%)
Will TXG be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for TXG based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for TXG
10x Genomics (TXG) Upgraded to Buy: Here's Why
TXG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for TXG
DraftKings, Flutter downgraded: Wall Street’s top analyst calls
TXG's price rises by 0.44% on November 3, though its technical setup remains stable.
Terex upgraded to Equal Weight from Underweight at Morgan Stanley
REV Group price target lowered to $55 from $64 at Morgan Stanley
Cautious Hold Rating Amid Strategic Merger Risks for Terex and REV Group